Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Thor

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Advances in Radiation Oncology|January 8, 2025
Cardiopulmonary Substructure Doses are Not Correlated With Cardiorespiratory Fitness Among Breast Cancer Survivors Treated With Contemporary Radiation TherapyMaria Thor, Jessica M Scott, Anne S Reiner, et al.
Physics and Imaging in Radiation Oncology|January 23, 2023
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancerJustin M Haseltine, Aditya Apte, Andrew Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2020
Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617Maria Thor, Joseph O Deasy, Chen Hu, et al.
Nature Communications|July 15, 2023
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLCJoao V Alessi, Biagio Ricciuti, Xinan Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 4, 2026
Safety profile of KRAS G12C inhibitors combined with thoracic radiation therapyDavid Gibbes Miller, Y Helen Zhang, Maria Thor, et al.
Medical Physics|September 20, 2018
Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncologyMartha M Matuszak, Clifton D Fuller, Torunn I Yock, et al.
Journal for Immunotherapy of Cancer|November 1, 2023
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancerJoao V Alessi, Adam Price, Allison L Richards, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415Maria Thor, Joseph O Deasy, Rebecca Paulus, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Advances in Radiation Oncology|January 8, 2025
Cardiopulmonary Substructure Doses are Not Correlated With Cardiorespiratory Fitness Among Breast Cancer Survivors Treated With Contemporary Radiation TherapyMaria Thor, Jessica M Scott, Anne S Reiner, et al.
Physics and Imaging in Radiation Oncology|January 23, 2023
Association of cardiac calcium burden with overall survival after radiotherapy for non-small cell lung cancerJustin M Haseltine, Aditya Apte, Andrew Jackson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2020
Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617Maria Thor, Joseph O Deasy, Chen Hu, et al.
Nature Communications|July 15, 2023
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLCJoao V Alessi, Biagio Ricciuti, Xinan Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 4, 2026
Safety profile of KRAS G12C inhibitors combined with thoracic radiation therapyDavid Gibbes Miller, Y Helen Zhang, Maria Thor, et al.
Medical Physics|September 20, 2018
Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncologyMartha M Matuszak, Clifton D Fuller, Torunn I Yock, et al.
Journal for Immunotherapy of Cancer|November 1, 2023
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancerJoao V Alessi, Adam Price, Allison L Richards, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415Maria Thor, Joseph O Deasy, Rebecca Paulus, et al.
Pageof 8